Genetically engineered mouse models (GEMM) allow investigation of tumor cells within an intact tumor microenvironment and have revealed a key role for MCL-1 in tumor development and maintenance of mammary cancer in vivo (Table 2). Here, MCL1 is linked to breast cancer.